Based on the results of Tuesday’s election, It’s just a matter of time before marijuana will become legal in all 50 states. A recent poll shows 93% of Americans are now in favor of legalization. And this poll doesn’t even account for the popularity and growing demand for CBD infused products, which will be legal in all 50 upon the imminent passage of the 2018 Farm Bill
According to a recent report issued by New Frontier Data, the U.S. CBD industry grew by nearly 40% in 2017, reaching $367 million in sales across hemp-derived (CBD) products. This marks the first year that sales of hemp-derived CBD products outpaced marijuana-derived CBD products.
Surging demand is expected to lift the industry higher; 2019 will be a break-out year for CBD, with the total market expanding to over $500 million in sales. The CBD industry will grow to $1.2 billion by 2020, and nearly $2 billion by 2022. The entire legal cannabis industry is expected to hit $57 billion by 2027.
With the legalization efforts in Michigan, Missouri, and Utah being successful from Tuesday’s election and yesterday’s announcement that Jeff Sessions has resigned from his post, the cannabis and CBD sector is poised to take off after a slight pullback after the Canadian legalization and run up to the midterm elections. With share prices down from earlier 52-week highs, there are many stocks that offer an attractive investment in the sector.
Aurora Cannabis Inc, the Canadian cannabis company which recently listed on the New York Stock Exchange, announced on Tuesday that it made an investment into Choom Holdings. The investment in Choom Holdings gives ACB more exposure to the Canadian marijuana retail segment, as Choom aims to become one of the largest adult-use cannabis retail networks in the country. Choom has obtained rights for 45 locations across Western Canada, which includes 27 development permits and 18 building permits in various cities.
New Age Beverages Corporation (NASDAQ:NBEV), the US based beverage producers which announced in September its expansion into CBD infused beverages, rose over 20% on the results of the election and the news of Sessions resignation. NBEV doubled its sales from 2016 and is poised to increase even more as it enters into the nascent CBD beverage space, which is complimenting its already robust offering of all-natural juices and energy beverages.
CV Sciences (OTC:CVSI), the US based company whose primary product is a chewing gum that combines CBD with nicotine, which is used in the treatment of addiction to smokeless tobacco. CSVI’s therapy product has significant upside for the legal-weed industry. The company’s product demonstrates that cannabis has uses that extend beyond its stereotypical image as a recreational drug, and the market has reacted very positively to the Company’s recent developments. CSVI posted over a 100% revenue gain from the 2016 to 2017 fiscal years, and surpassed its 2017 sales figure through the first 6 months of fiscal 2018.
American Premium Water Corporation (OTC:HIPH) the US based beverage marketer and distributor announced last week that had acquired proprietary formulations to Hydro-Nano infused energy, CBD, and THC beverages. HIPH’s technology allows for a 90% higher absorption rate than regular CBD and THC beverages. This Company could be the biggest bargain of them all, as it recently closed below $0.05 when it was recently given a price target of $0.30 by SeeThru Equity.
Canaccord’s Bobby Burleson and Jonathan DeCourcey claimed that the drinks could be poised to outpace general demand for marijuana products by over two times, capturing 20% of the market for cannabis edibles by 2022.
Just like a coach draws up a game plan before a team takes the field, investors should take advantage of the October pullback before the post-election cannabis rush takes full effect, and these stocks are all poised to score a touchdown.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as
“may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You
should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CG undertakes no obligation to update such statements.
You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. CG was not compensated by (NYSE: ACB), (NASDAQ: NBEV), (OTC:CSVI), (OTC:HIPH) or any other company mentioned in this article.
Full Disclaimer: http://www.cannagreed.com/disclaimer/